[1] 陈新,徐文华,周健,等.口腔鳞状细胞癌现状[J].口腔医学,2017,37(5): 462-465. [2] 程伟,童昕,马建民,等.CXC类趋化因子受体4在口腔鳞状细胞癌中的表达及临床意义[J].国际口腔医学杂志,2010,37(5):502-503. [3] 孙志伟,王晰程,高静,等.结直肠癌中ABCG2 表达与伊立替康为基础化疗疗效相关性研究[J].中国肿瘤临床,2014,41(7):430-433. [4] Lee SH, Kim H, Hwang JH, et al. Breast cancer resistance protein expression is associated with early recurrence and decreased survival in resectable pancreatic cancer patients [J]. Pathol Int, 2012, 62(3): 167-175. [5] Wójcicka A, Kolanowska M, Jazdzewski K. MECHANISMS IN ENDOCRINOLOGY: MicroRNA in diagnostics and therapy of thyroid cancer [J]. Eur J Endocrinol, 2016, 174(3): R89-R98. [6] Yu H, Gao G, Jiang L, et al. Decreased expression of miR-218 is associated with poor prognosis in patients with colorectal cancer [J]. Int J Clin Exp Pathol, 2013, 6(12): 2904-2911. [7] Volinia S, Galasso M, Sana ME, et al. Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA [J]. Proc Natl Acad Sci U S A, 2012, 109(8): 3024-3029. [8] Peng SC, Liao CT, Peng CH, et al. MicroRNAs miR-218, miR-125b, and Let-7g predict prognosis in patients with oral cavity squamous cell carcinoma [J]. PLoS One, 2014, 9(7): e102403. [9] Singh V, Husain N, Akhtar N, et al. p16 and p53 in HPV-positive versus HPV-negative oral squamous cell carcinoma: do pathways differ [J]. J Oral Pathol Med, 2017, 46(9): 744-751. [10] 王倩,侯大为.口腔鳞状细胞癌发病及转移机制研究进展[J].口腔医学研究,2018,34(11): 1164-1167. [11] Kozomara A, Griffiths JS. miRBase: annotating high confidence microRNAs using deep sequencing data [J]. Nucleic Acids Res, 2014, 42(D1): D68-D73. [12] Kim VN. MicroRNA biogenesis: coordinated cropping and dicing [J]. Nat Rev Mol Cell Biol, 2005, 6(5): 376-385. [13] Fukumoto I, Hanazawa T, Kinoshita T, et al. MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathways [J]. Br J Cancer, 2015, 112(5): 891-900. [14] Chang CC, Yang YJ, Li YJ, et al. MicroRNA-17/20a functions to inhibit cell migration and can be used a prognostic marker in oral squamous cell carcinoma [J]. Oral Oncology, 2013, 49(9): 923-931. [15] Peng CY, Liao YW, Lu MY, et al. Downregulation of miR-1 enhances tumorigenicity and invasiveness in oral squamous cell carcinomas [J]. J Formos Med Assoc, 2017, 116(10): 782-789. [16] Joshi AA, Vaidya SS, Stpierre MV, et al. Placental ABC transporters: biological impact and pharmaceutical significance [J]. Pharm Res, 2016, 33(12): 1-32. [17] Natarajan K, Xie Y, Baer MR, et al. Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance [J]. Biochem Pharmacol, 2012, 83(8): 1084-1103. [18] 赵凌冰,王新星,李晓梅,等.P-gp和ABCG2在口腔鳞状细胞癌中的表达及临床病理意义[J].口腔医学研究,2012,28(1): 32-35. [19] 吕弢,俞兴旺,胡静,等.miR-144-3p靶向调控ABCG2信号通路对胃癌细胞侵袭和迁移的影响[J].世界华人消化杂志,2018,26(28): 1635-1644. |